Not All Injection Drug Users Are Created Equal: Heterogeneity of HIV, Hepatitis C Virus, and Hepatitis B Virus Infection in Georgia

References

• Alcabes P., Friedland G. Injection drug use and human immunodeficiency virus infection. Clinical Infectious Diseases 1995; 20: 1467–1479
   PubMed Web of Science ®Google Scholar
• Boileau C., Bruneau J., Al Nachawati H., Lamothe F., Vincelette J. A prognostic model for HIV seroconversion among injection drug users as a tool for stratification in clinical trials. Journal of Acquired Immune Deficiency Syndromes 2005; 39: 489–495
   Google Scholar
• Butsashvili M., Tsertsvadze T., McNutt L. A., Kamkamidze G., Gvetadze R., Badridze N. Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors. European Journal of Epidemiology 2001; 17: 693–695
   Google Scholar
• DeBell D., Carter R. Impact of transition on public health in Ukraine: case study of the HIV/AIDS epidemic. British Medical Journal 2005; 331: 216–219
   PubMed Web of Science ®Google Scholar
• Delage G., Infante-Rivard C., Chiavetta J. A., Willems B., Pi D., Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology 1999; 116: 893–899
   PubMed Web of Science ®Google Scholar
• Diaz T., Des J., Vlahov D., Perlis T. E., Edwards V., Friedman S. R., et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. American Journal of Public Health 2001; 91: 23–30
   PubMed Web of Science ®Google Scholar
• Girardi E., Zaccarelli M., Tossini G., Puro V., Narciso P., Visco G. Hepatitis C virus infection in intravenous drug users: prevalence and risk factors. Scandinavian Journal of Infectious Diseases 1990; 22: 751–752
   PubMed Web of Science ®Google Scholar
• Kazionny B., Wells C. D., Kluge H., Gusseynova N., Molotilov V. Implications of the growing HIV-1 epidemic for tuberculosis control in Russia. Lancet 2001; 358: 1513–1514
   PubMed Web of Science ®Google Scholar
• Kelly J. A., Amirkhanian Y. A. The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe. International Journal of STD and AIDS 2003; 14: 361–371
   PubMed Web of Science ®Google Scholar
• McMahon B. J. Epidemiology and natural history of hepatitis B. Seminars in Liver Disease 2005; 25(Suppl. 1)3–8
   PubMed Web of Science ®Google Scholar
• Mikhailov M. I., Gomberg M. A., Dolzhanskaya N. A., Koubanova A. A. Significance of sexual route of transmission of hepatitis B and C in Russia. International Journal of STD and AIDS 2002; 13(Suppl 2)9–11
   Google Scholar
• Millson P., Myers T., Calzavara L., Wallace E., Major C., Degani N. Regional variation in HIV prevalence and risk behaviours in Ontario injection drug users (IDU). Canadian Journal of Public Health 2003; 94: 431–435
   PubMed Web of Science ®Google Scholar
• Parfitt T. Designer drug Subutex takes its toll in Tbilisi. Lancet 2006; 368: 273–274
   PubMed Web of Science ®Google Scholar
• Rhodes T., Lowndes C., Judd A., Mikhailova L. A., Sarang A., Rylkov A., et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS 2002; 16: F25–F31
   PubMed Web of Science ®Google Scholar
• Rhodes T., Platt L., Maximova S., Koshkina E., Latishevskya N., Hickman M., et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction 2006; 101: 252–266
   PubMed Web of Science ®Google Scholar
• Sanchez J. L., Todd C. S., Bautista C. T., Botros B. A., Khakimov M. M., Giyasova G. M., et al. High HIV prevalence and risk factors among injection drug users in Tashkent, Uzbekistan, 2003-2004. Drug and Alcohol Dependence 2006; 82(Suppl 1)S15–22
   Google Scholar
• Shakarishvili A., Dubovskaya L. K., Zohrabyan L. S., St Lawrence J. S., Aral S. O., Dugasheva L. G., et al. Sex work, drug use, HIV infection, and spread of sexually transmitted infections in Moscow, Russian Federation. Lancet 2005; 366: 57–60
   PubMed Web of Science ®Google Scholar
• Shapatava E., Nelson K. E., Tsertsvadze T., del Rio C. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia. Drug and Alcohol Dependence 2006; 82(Suppl 1)S35–S38
   PubMed Web of Science ®Google Scholar
• Shepard C. W., Finelli L., Alter M. J. Global epidemiology of hepatitis C virus infection. Lancet Infectious Diseases 2005; 5: 558–567
   PubMed Web of Science ®Google Scholar
• Strathdee S. A., Galai N., Safaiean M., Celentano D. D., Vlahov D., Johnson L., et al. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Archives of Internal Medicine 2001; 161: 1281–1288
   PubMed Web of Science ®Google Scholar
• Stvilia K., Tsertsvadze T., Sharvadze L., Aladashvili M., del Rio C., Kuniholm M. H., et al. Prevalence of Hepatitis C, HIV, and Risk Behaviors for Blood-Borne Infections: A Population-Based Survey of the Adult Population of T'bilisi, Republic of Georgia. Journal of Urban Health 2006; 83: 289–298
   Google Scholar
• Thomas D. L., Vlahov D., Solomon L., Cohn S., Taylor E., Garfein R., et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995; 74: 212–220
   PubMed Web of Science ®Google Scholar
• Tkeshelashvilli-Kessler A., del Rio C., Nelson K., Tsertsvadze T. The emerging HIV/AIDS epidemic in Georgia. International Journal of STD and AIDS 2005; 16: 61–67
   Google Scholar
• United Nations Office for Drug Control and Crime Prevention. Illicit drug situation in the regions neighboring Afganistan and response of ODCCP. 2002
   Google Scholar
• United Nations Office on Drugs and Crime. World Drug Report 2005. 2005
   Google Scholar
• United States Department of State. 1996 International Narcotics Control Strategy Report. 1996
   Google Scholar
• United States Department of State. 2005 International Narcotics Control Strategy Report. 2005
   Google Scholar
• United States Drug Enforcement Administration. Heroin Trafficking in Russia's Troubled East. 2003, DEA-03053
   Google Scholar
• Vu M. Q., Steketee R. W., Valleroy L., Weinstock H., Karon J., Janssen R. HIV incidence in the United States, 1978-1999. Journal of Acquired Immune Deficiency Syndromes 2002; 31: 188–201
   PubMed Web of Science ®Google Scholar
• Zaller N., Nelson K. E., Aladashvili M., Badridze N., del Rio C., Tsertsvadze T. Risk factors for hepatitis C virus infection among blood donors in Georgia. European Journal of Epidemiology 2004; 19: 547–553
   PubMedGoogle Scholar